Index Performance
Index performance of price, total return net and total return gross indices is displayed in realtime.
| Period | Price | Total Return Net | Total Return Gross |
| Year-to-Date Performance | 13.25% | 13.61% | 13.74% |
| 1-Year Performance | -3.07% | -2.59% | -2.42% |
| 3-Year Performance | 9.96% | 11.72% | 12.38% |
| 5-Year Performance | 23.68% | 26.50% | 27.58% |
| Since Inception (29 Sep 2000) | 195.05% | 204.43% | 311.76% |
Index Records
Index highs and lows of price, total return net and total return gross indices are displayed in realtime.
| Period | Price | Total Return Net | Total Return Gross |
| All Time High/Low | 3,367.70 / 312.69 | 3,403.35 / 312.71 | 4,567.29 / 1,000.00 |
| 52-Weeks High/Low | 3,170.78 / 2,421.18 | 3,257.19 / 2,490.21 | 4,398.71 / 3,364.26 |
| Quarter High/Low | 3,066.09 / 2,863.79 | 3,161.14 / 2,952.56 | 4,274.43 / 3,992.40 |
| Month High/Low | 2,968.28 / 2,863.79 | 3,060.30 / 2,952.56 | 4,138.08 / 3,992.40 |
Index Correlation and Volatility
Index correlation to selected index peers and index volatility are updated daily.
| Index Correlation | |
| MSCI ACWI Biotechnology | 0.8743 |
| DJ US Biotechnology TSM | 0.9377 |
| Index Volatility | |
| 22-day Volatility | 18.90 |
| 250-day Volatility | 22.88 |
Component Performance
Displayed are the best and worst index components over a selected period of time. Data is updated daily.
| Best 5 Components | 1-Year | Year-to-Date | 1-Day |
| ALEXION PHARMACEUTICALS INC | -1.84% | 17.95% | 3.06% |
| AMGEN INC | 6.54% | 7.25% | 0.38% |
| BIOGEN INC | -32.07% | -22.51% | 0.82% |
| BIOMARIN PHARMACEUTICAL INC | -21.58% | -8.14% | 2.24% |
| CELGENE CORP | 4.91% | 49.29% | 0.44% |
| CHARLES RIVER LABORATORIES | 7.92% | 14.59% | 0.20% |
| GILEAD SCIENCES INC | -9.41% | 4.50% | 1.09% |
| ILLUMINA INC | -12.35% | -3.14% | 2.06% |
| INCYTE CORP | 23.63% | 35.35% | 2.34% |
| REGENERON PHARMACEUTICALS | -21.34% | -20.27% | 0.59% |
| SEATTLE GENETICS INC | 6.19% | 41.14% | 1.70% |
| UNITED THERAPEUTICS CORP | -35.38% | -23.99% | 1.81% |
| VERTEX PHARMACEUTICALS INC | 5.39% | 12.49% | 1.46% |
| ALNYLAM PHARMACEUTICALS INC | -14.49% | 14.35% | 1.50% |
| GRIFOLS SA-ADR | 8.89% | 21.81% | 0.73% |
| ALLERGAN PLC | -13.94% | 22.52% | 1.34% |
| BLUEBIRD BIO INC | -25.50% | 19.26% | -2.67% |
| IONIS PHARMACEUTICALS INC | 35.49% | 33.46% | 1.65% |
| NEUROCRINE BIOSCIENCES INC | -14.05% | 37.73% | 1.36% |
| QIAGEN NV | -9.00% | 1.02% | 1.84% |
| IQVIA HOLDINGS INC | 28.30% | 35.31% | 1.53% |
| NEKTAR THERAPEUTICS | -72.55% | -48.25% | -0.58% |
| EXACT SCIENCES CORP | 138.22% | 88.95% | -0.19% |
| SAREPTA THERAPEUTICS INC | -21.40% | -6.99% | -0.56% |
| BEIGENE LTD-ADR | -10.59% | 4.12% | 0.61% |
| Worst 5 Components | 1-Year | Year-to-Date | 1-Day |
| ALEXION PHARMACEUTICALS INC | -1.84% | 17.95% | 3.06% |
| AMGEN INC | 6.54% | 7.25% | 0.38% |
| BIOGEN INC | -32.07% | -22.51% | 0.82% |
| BIOMARIN PHARMACEUTICAL INC | -21.58% | -8.14% | 2.24% |
| CELGENE CORP | 4.91% | 49.29% | 0.44% |
| CHARLES RIVER LABORATORIES | 7.92% | 14.59% | 0.20% |
| GILEAD SCIENCES INC | -9.41% | 4.50% | 1.09% |
| ILLUMINA INC | -12.35% | -3.14% | 2.06% |
| INCYTE CORP | 23.63% | 35.35% | 2.34% |
| REGENERON PHARMACEUTICALS | -21.34% | -20.27% | 0.59% |
| SEATTLE GENETICS INC | 6.19% | 41.14% | 1.70% |
| UNITED THERAPEUTICS CORP | -35.38% | -23.99% | 1.81% |
| VERTEX PHARMACEUTICALS INC | 5.39% | 12.49% | 1.46% |
| ALNYLAM PHARMACEUTICALS INC | -14.49% | 14.35% | 1.50% |
| GRIFOLS SA-ADR | 8.89% | 21.81% | 0.73% |
| ALLERGAN PLC | -13.94% | 22.52% | 1.34% |
| BLUEBIRD BIO INC | -25.50% | 19.26% | -2.67% |
| IONIS PHARMACEUTICALS INC | 35.49% | 33.46% | 1.65% |
| NEUROCRINE BIOSCIENCES INC | -14.05% | 37.73% | 1.36% |
| QIAGEN NV | -9.00% | 1.02% | 1.84% |
| IQVIA HOLDINGS INC | 28.30% | 35.31% | 1.53% |
| NEKTAR THERAPEUTICS | -72.55% | -48.25% | -0.58% |
| EXACT SCIENCES CORP | 138.22% | 88.95% | -0.19% |
| SAREPTA THERAPEUTICS INC | -21.40% | -6.99% | -0.56% |
| BEIGENE LTD-ADR | -10.59% | 4.12% | 0.61% |
